罗欣药业：控股股东部分股份解除质押及再质押

Core Viewpoint - The announcement from Luoxin Pharmaceutical indicates recent changes in the share pledging status of its controlling shareholder, Luoxin Holdings, which involves both the release and new pledging of shares without substantial impact on the company [1] Summary by Relevant Sections - Share Pledge Release and New Pledge - On October 31, Luoxin Holdings released a pledge of 102 million shares, accounting for 43.23% of its holdings and 9.42% of the company's total share capital [1] - On the same day, Luoxin Holdings pledged 101 million shares, representing 42.75% of its holdings and 9.31% of the company's total share capital [1] - Cumulative Pledge Status - As of the announcement date, Luoxin Holdings and its concerted parties have a total of 137 million pledged shares, which constitutes 56.83% of their holdings and 12.63% of the company's total share capital [1] - Impact on the Company - The current pledging activities are not intended to meet the operational needs of the listed company and are stated to have no substantial impact on the company [1]